As the title, I just got appointed as “Editorial Board Members” of the new journal “Organs-on-a-Chip”! From this September, this journal is now open for submission. If you have good manuscripts, please submit!! https://www.journals.elsevier.com/organs-on-a-chip/editorial-board
Two students supported by Nakatani RIES students from U. Heidelberg have come to our group! They will conduct the Body-on-a-Chip projects in collaboration with Prof. Hirai and Tabata for 6 weeks.
The interview of Dr. Kamei got appeared on “Sensei Theater” of Kyoto University! Please find the video from the link below.
Our patent about the new chemical materials for nanofibers to maintain stem cells got registered on the JPO and USPO!
We published some papers, recently! So we have updated “Publications” page accordingly. Please take a look!
A new research assistant, Dr. Wen and a new undergrad research assistant, Mr. Kawasaki have joined our group, today. Welcome!
iCeMS is to co-host a symposium “Shaping Self-Assembled Mesoscale (Bio)Materials with Microengineering” as follows. Date March 28, 20199:20-17:40 Venue KUIAS/iCeMS Main Building 2F Seminar Room (A207) Access Attendance Fee Free Registration Not required Language English HostContact Symposium secretariatsiCeMS Furukawa Lab： furukawa-g [at] icems.kyoto-u.ac.jpor iCeMS Kamei Lab： kamei-g [at] icems.kyoto-u.ac.jp
Finally, our patent about a microfluidic device enabling 3D culture of human pluripotent stem cells got registered on the register of the Japan Patent Office. Accordingly, we have updated “Patents” page on this website.
Dr. Kamei and his colleagues of iCeMS Caravan had visited Oosaka Jogakuin High School on March 9. In this project, iCeMS scientists deliver their original active-learning program to high schools. ///from iCeMS web page/// In this 9th visit of the Caravan, four scientists including Drs Ken-ichiro Kamei (engineer), Monamie Ringhofer Read more…
Help Us, Help the World Visionary science requires visionary philanthropy. It is a sad but true fact that truly transformative science is often the hardest to fund. Risk-taking is admired in fields as diverse as professional sports and stock market trading, but the minute a scientist dons a white lab Read more…